Biogen (BIIB) Return on Assets (2009 - 2026)
Biogen (BIIB) posted quarterly Return on Assets of 0.0% for Q2 2026, little changed year-over-year from 0.0% in Q2 2025, and down 41.78% quarter-over-quarter from 0.0% in Q1 2026.
Biogen (BIIB) Return on Assets (2009 - 2026) Analysis & Trends
Biogen's Return on Assets history runs 18 years deep, the most recent figure standing at 0.0% for Q2 2026.
- In Q2 2026, Return on Assets changed 0.0% year-over-year to 0.0%; the TTM figure through Jun 2026 stood at 0.0% (changed 0.0% YoY), while the FY2025 annual figure was 0.0%, changed 0.0% from the prior year.
- Return on Assets for Q2 2026 stood at 0.0%, down from 0.0% in the prior quarter.
- The five-year high for Return on Assets was 0.0% in Q1 2023, with the low at 0.0% in Q2 2026.
- The 5-year median for Return on Assets is 0.0% (2023), against an average of 0.0%.
- Peak annual rise in Return on Assets reached 0 bps in 2022, while the deepest fall reached 0 bps in 2022.
- Biogen's Return on Assets stood at 0.0% in 2022, then tumbled by 65 bps to 0.0% in 2023, then soared by 37 bps to 0.0% in 2024, then declined by 24 bps to 0.0% in 2025, then slumped by 39 bps to 0.0% in 2026.
- Business Quant data shows BIIB's Return on Assets at 0.0% in Q2 2026, 0.0% in Q1 2026, and 0.0% in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn | 0.00% |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn | 0.00% |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn | 0.00% |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn | 0.00% |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn | 0.00% |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn | 0.00% |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn | 0.00% |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn | 0.00% |
| 10 | Biogen | 32.04 Bn | 30.76 Bn | 1.96 Bn | 0.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.00% |
| Mar 31, 2026 | 0.00% |
| Dec 31, 2025 | 0.00% |
| Sep 30, 2025 | 0.00% |
| Jun 30, 2025 | 0.00% |
| Mar 31, 2025 | 0.00% |
| Dec 31, 2024 | 0.00% |
| Sep 30, 2024 | 0.00% |
| Jun 30, 2024 | 0.00% |
| Mar 31, 2024 | 0.00% |
| Dec 31, 2023 | 0.00% |
| Sep 30, 2023 | 0.00% |
| Jun 30, 2023 | 0.00% |
| Mar 31, 2023 | 0.00% |
| Dec 31, 2022 | 0.00% |
| Sep 30, 2022 | 0.00% |
| Jun 30, 2022 | 0.00% |
| Mar 31, 2022 | 0.00% |
| Dec 31, 2021 | 0.00% |
| Sep 30, 2021 | 0.00% |